MSL Visibility - How to SUCCEED in 2024

In episode 186, Tom Caravela welcomes Eleonora Goldberg to explore the evolving role of Medical Science Liaisons (MSLs) within organizations. They delve into the key attributes leaders seek in MSLs and share strategies for standing out and enhancing team performance. Essential skills for MSL effectiveness and methods for evaluating performance are discussed, alongside preparing for industry changes and maintaining positivity in 2024. Eleonora offers predictions and expresses optimism for the future of MSLs. The episode concludes with closing remarks, appreciation, and a reminder to subscribe and stay engaged.

My guest this week is Eleonora Goldberg, Vice President, Medical Affairs at Arrowhead Pharmaceuticals and we discuss MSL Visibility and how to succeed in 2024.

 Eleonora shares….

👉 What is the VALUE of MSLs
👉 What leaders look for in MSLs
👉 How can MSLs separate themselves from their peers
👉 How might 2024 be different for MSLs
👉 What advice is there for dealing with uncertainty

PLEASE sign up for the MSL Talk Podcast Newsletter here: https://www.mslmastery.com/msl-talk-podcast-newsletter-signup

The MSL Talk Podcast is available on all podcast platforms and the MSL Talk YouTube Channel. 

MSL Talk is a podcast that features helpful information for current Medical Science Liaisons, Medical Affairs leaders, job seekers looking to break into the pharmaceutical industry in their first MSL role as well as anyone interested in hearing good industry conversation and medical affairs discussions.

#msl #medicalaffairs #medicalscienceliaison #MSLTalk #pharmaceutical

(0:00) Introduction to episode and guest Eleonora Goldberg
(3:10) Discussing the value of MSLs in the organization
(5:27) Key attributes leaders look for in MSLs
(9:12) Strategies for MSLs to stand out and elevate team performance
(14:03) Essential skills for MSL effectiveness
(17:22) Evaluating MSL performance and metrics
(19:56) Preparing for industry changes and staying positive in 2024
(26:06) Predictions and optimism for the future of MSLs
(27:15) Closing remarks and appreciation
(27:48) Subscription reminder and farewell